ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Actuate Therapeutics Inc

Actuate Therapeutics Inc (ACTU)

8.11
-0.73
( -8.26% )
更新日時: 02:51:09

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
8.11
買値
8.11
売値
8.24
出来高
9,912
8.03 日の範囲 9.02
5.00 52 週間の範囲 10.162
時価総額
前日終値
8.84
始値
9.02
最終取引時間
02:52:19
財務取引量
US$ 85,282
VWAP
8.6039
平均取引量 (3 か月)
58,749
発行済株式数
19,531,636
配当利回り
-
PER
-6.39
1 株当たり利益 (EPS)
-1.27
歳入
-
純利益
-24.75M

Actuate Therapeutics Inc について

Actuate Therapeutics is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is des... Actuate Therapeutics is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B. We believe that the blockade of GSK-3B signaling ultimately results in the death of the cancer cells and the regulation of anti-tumor immunity. We have exclusively licensed a portfolio of GSK-3 inhibitors developed in a collaboration between the University of Illinois-Chicago (UIC) and Northwestern University (NU). 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Actuate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ACTU. The last closing price for Actuate Therapeutics was US$8.84. Over the last year, Actuate Therapeutics shares have traded in a share price range of US$ 5.00 to US$ 10.162.

Actuate Therapeutics currently has 19,531,636 shares in issue. The market capitalisation of Actuate Therapeutics is US$172.66 million. Actuate Therapeutics has a price to earnings ratio (PE ratio) of -6.39.

ACTU 最新ニュース

Actuate Names 2010 North American Excellence Award Winners

Actuate Corporation (NASDAQ: ACTU) (NASDAQ: BIRT), The people behind BIRT® and the leading open source Business Intelligence vendor, today announced that it has recognized...

BIRT Downloads Surpass 10 Million With Over One Million Developers Using BIRT Worldwide

Actuate Corporation (NASDAQ:BIRT), The people behind BIRT® and the leading open source Business Intelligence vendor, today reported that BIRT has now been downloaded over 10...

Actuate Reports Third Quarter 2010 Financial Results

Actuate Corporation (NASDAQ: ACTU)(NASDAQ: BIRT), the people behind BIRT® and the leading open source Business Intelligence vendor, today announced financial results for the...

Actuate (Nasdaq: ACTU) to Change Ticker Symbol to 'BIRT' Effective November 3, 2010

Actuate Corporation (NASDAQ:ACTU), The people behind BIRT® and the leader in open source Business Intelligence (BI), today announced that The Nasdaq Stock Market has approved...

Actuate Announces Lineup for International Customer Days

Actuate Corporation (NASDAQ:ACTU), The people behind BIRT® and the leading open source Business Intelligence vendor, today announced the highlights of its upcoming Actuate...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
11.2918.91495601176.828.936.27732727.88347437CS
4-0.04-0.4907975460128.15106.27780637.96547591CS
121.1115.85714285717106.27587498.23205583CS
263.1162.2510.1625395618.08947955CS
523.1162.2510.1625199398.08947955CS
1563.1162.2510.162566208.08947955CS
2603.1162.2510.162546768.08947955CS

ACTU - Frequently Asked Questions (FAQ)

What is the current Actuate Therapeutics share price?
The current share price of Actuate Therapeutics is US$ 8.11
How many Actuate Therapeutics shares are in issue?
Actuate Therapeutics has 19,531,636 shares in issue
What is the market cap of Actuate Therapeutics?
The market capitalisation of Actuate Therapeutics is USD 172.66M
What is the 1 year trading range for Actuate Therapeutics share price?
Actuate Therapeutics has traded in the range of US$ 5.00 to US$ 10.162 during the past year
What is the PE ratio of Actuate Therapeutics?
The price to earnings ratio of Actuate Therapeutics is -6.39
What is the reporting currency for Actuate Therapeutics?
Actuate Therapeutics reports financial results in USD
What is the latest annual profit for Actuate Therapeutics?
The latest annual profit of Actuate Therapeutics is USD -24.75M
What is the registered address of Actuate Therapeutics?
The registered address for Actuate Therapeutics is 108 LAKELAND AVE, KENT, DOVER, DELAWARE, 19901
What is the Actuate Therapeutics website address?
The website address for Actuate Therapeutics is www.actuatetherapeutics.com
Which industry sector does Actuate Therapeutics operate in?
Actuate Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NXUNXU Inc
US$ 1.885
(674.45%)
466.66M
WATTEnergous Corporation
US$ 1.485
(261.14%)
168.7M
INTZIntrusion Inc
US$ 5.35
(147.69%)
115.82M
SMXSMX Security Matters Public Company
US$ 0.8276
(134.05%)
177.94M
JDZGJIADE Ltd
US$ 1.49
(112.80%)
8.81M
ABPAbpro Holdings Inc
US$ 2.20
(-51.00%)
1.54M
TRAWTraws Pharma Inc
US$ 7.72
(-42.47%)
931k
SHOTWSafety Shot Inc
US$ 0.13
(-27.90%)
1.25k
LITMSnow Lake Resources Ltd
US$ 1.16
(-27.50%)
46.21M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 66.9375
(-24.33%)
9.39k
NXUNXU Inc
US$ 1.885
(674.45%)
466.66M
VINCVincerx Inc
US$ 0.3436
(77.11%)
308.08M
XTIAXTI Aerospace Inc
US$ 0.0399
(1.01%)
187.57M
SMXSMX Security Matters Public Company
US$ 0.8276
(134.05%)
177.94M
WATTEnergous Corporation
US$ 1.485
(261.14%)
168.7M

ACTU Discussion

投稿を表示

最近閲覧した銘柄